<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="molecules-26-00264-t001" orientation="portrait" position="float">
 <object-id pub-id-type="pii">molecules-26-00264-t001_Table 1</object-id>
 <label>Table 1</label>
 <caption>
  <p>Biological activities reported for the isoflavonoids isolated from 
   <italic>Iris germanica</italic>.
  </p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Compound</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Bioactivity</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Reference</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Germanaism A (
     <bold>1</bold>)
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic activity IC
     <sub>50</sub> = 43.9 ± 1.5 μM (MTT); 4.5 ± 0.4 μM (ATP)
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B34-molecules-26-00264" ref-type="bibr">34</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tectoridin (
     <bold>9</bold>)
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Free-radical scavenger, antioxidant, anti-inflammatory, antiproliferative, oestrogenic, anti-alcohol injury, hepatoprotective effects</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B48-molecules-26-00264" ref-type="bibr">48</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Iridin (
     <bold>10</bold>)
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Potent anti-inflammatory effects (induced paw edema test)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B24-molecules-26-00264" ref-type="bibr">24</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Iridin A (
     <bold>11</bold>)
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">High antioxidant activity;
     <break/>α-amylase inhibitory activity
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B38-molecules-26-00264" ref-type="bibr">38</xref>,
     <xref rid="B40-molecules-26-00264" ref-type="bibr">40</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Irisolidone 7-
     <italic>O</italic>-β-
     <sc>d</sc>-glucopyranoside (
     <bold>14</bold>)
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CyP1A inhibitor; QR inhibitor; DPPH scavenger</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Irilone (
     <bold>17</bold>)
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic activity IC
     <sub>50</sub> = 47.7 ± 3.5 μM (MTT), 17.7 ± 1.4 μM (ATP);
     <break/>potent anti-inflammatory effects (induced paw edema test): 
     <break/>high antioxidant activity;
     <break/>α-amylase inhibitory activity;
     <break/>potent inhibitor of cytochrome P450 1A activity (IC
     <sub>50</sub> = 0.3 ± 0.1 μM); immunomodulatory activity; CyP1A inhibitor; moderate QR inhibitor; DPPH scavenger
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B34-molecules-26-00264" ref-type="bibr">34</xref>]
     <break/>[
     <xref rid="B24-molecules-26-00264" ref-type="bibr">24</xref>]
     <break/>[
     <xref rid="B38-molecules-26-00264" ref-type="bibr">38</xref>,
     <xref rid="B40-molecules-26-00264" ref-type="bibr">40</xref>]
     <break/>[
     <xref rid="B42-molecules-26-00264" ref-type="bibr">42</xref>]
     <break/>[
     <xref rid="B43-molecules-26-00264" ref-type="bibr">43</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Irilone 4′-
     <italic>O</italic>-β-
     <sc>d</sc>-glucopyranoside (
     <bold>19</bold>)
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Potent anti-inflammatory effects (induced paw edema test)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B24-molecules-26-00264" ref-type="bibr">24</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8-Hydroxyirilone (
     <bold>21</bold>)
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">High antioxidant activity; α-amylase inhibitory activity</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B38-molecules-26-00264" ref-type="bibr">38</xref>,
     <xref rid="B40-molecules-26-00264" ref-type="bibr">40</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8-Hydroxyirilone 5-methyl ether (
     <bold>22</bold>)
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">High antioxidant activity;
     <break/>α-amylase inhibitory activity
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B38-molecules-26-00264" ref-type="bibr">38</xref>,
     <xref rid="B40-molecules-26-00264" ref-type="bibr">40</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Iriflogenin (
     <bold>23</bold>)
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Potent inhibitor of cytochrome P450 1A activity (IC
     <sub>50</sub> = 1.4 ± 0.6 μM); CyP1A inhibitor; weak DPPH scavenger
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B42-molecules-26-00264" ref-type="bibr">42</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Irifloside (
     <bold>25</bold>)
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic activity IC
     <sub>50</sub> = 21.5 ± 4.4 μM (MTT); 19.4 ± 1.3 μM (ATP)
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B34-molecules-26-00264" ref-type="bibr">34</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Irisolone (nigricin) (
     <bold>28</bold>)
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">High anti-inflammatory activity</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B14-molecules-26-00264" ref-type="bibr">14</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nigricanin (iriskashmirianin) (
     <bold>29</bold>)
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CyP1A inhibitor; moderate QR inhibitor; weak DPPH scavenger</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B42-molecules-26-00264" ref-type="bibr">42</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Iriskashmirianin A (
     <bold>30</bold>)
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic activity IC
     <sub>50</sub> = 20.9 ± 2.7 μM (MTT); 4.3 ± 0.9 μM (ATP)
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B34-molecules-26-00264" ref-type="bibr">34</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5,7-Dihydroxy-3-(3′-hydroxy-4′,5′-dimethoxy)-8-methoxy-4H-1-benzopyran-4-one (
     <bold>33</bold>)
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Significant anti-inflammatory activity</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B14-molecules-26-00264" ref-type="bibr">14</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tectorigenin (
     <bold>35</bold>)
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antifungal, free radical scavenger, antioxidant, anti-inflammatory, anti-angiogenic, antiproliferative, antineoplastic, hypoglycaemic, oestrogenic, hepatoprotectiv, antithrombotic, cardiovascular, anti-alcohol injury activities;
     <break/>in patented pharmaceutical compositions for the treatment of hormone-related diseases
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B48-molecules-26-00264" ref-type="bibr">48</xref>,
     <xref rid="B49-molecules-26-00264" ref-type="bibr">49</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Irigenin (
     <bold>37</bold>)
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Potent anti-inflammatory effects (induced paw edema test and inhibition against superoxide); α-amylase inhibitory activity; potent inhibitor of cytochrome P450 1A activity (IC
     <sub>50</sub> = 1.2 ± 0.3 μM); CyP1A inhibitor; moderate QR inhibitor, DPPH scavenger
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B14-molecules-26-00264" ref-type="bibr">14</xref>,
     <xref rid="B24-molecules-26-00264" ref-type="bibr">24</xref>]
     <break/>[
     <xref rid="B38-molecules-26-00264" ref-type="bibr">38</xref>,
     <xref rid="B40-molecules-26-00264" ref-type="bibr">40</xref>]
     <break/>[
     <xref rid="B42-molecules-26-00264" ref-type="bibr">42</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Irigenin S (
     <bold>38</bold>)
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Potent anti-inflammatory effects (induced paw edema test)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B24-molecules-26-00264" ref-type="bibr">24</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Irisolidone (
     <bold>42</bold>)
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Potent anti-inflammatory effects (induced paw edema test);
     <break/>α-amylase inhibitory activity; immunomodulatory activity; CyP1A inhibitor; QR inhibitor; DPPH scavenger; antiproliferative activity against amelanotic melanoma and large lung carcinoma cells; antioxidant properties
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B24-molecules-26-00264" ref-type="bibr">24</xref>]
     <break/>[
     <xref rid="B38-molecules-26-00264" ref-type="bibr">38</xref>,
     <xref rid="B40-molecules-26-00264" ref-type="bibr">40</xref>]
     <break/>[
     <xref rid="B43-molecules-26-00264" ref-type="bibr">43</xref>]
     <break/>[
     <xref rid="B50-molecules-26-00264" ref-type="bibr">50</xref>]
     <break/>[
     <xref rid="B51-molecules-26-00264" ref-type="bibr">51</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Iristectorigenin A (
     <bold>43</bold>)
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Weak anti-inflammatory activity</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B14-molecules-26-00264" ref-type="bibr">14</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Isoflavone (
     <bold>44</bold>)
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Moderate anti-inflammatory activity</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B14-molecules-26-00264" ref-type="bibr">14</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5,7,8-Trihydroxy-3-(4-methoxyphenyl)-2-methyl-4
     <italic>H</italic>-chromen-4-one (
     <bold>47</bold>)
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Significant inhibition of TRAP in NF-kB ligand-induced osteoclastic RAW 264.7 cells (66.67 ± 2.71%)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B47-molecules-26-00264" ref-type="bibr">47</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6,7-Dihydroxy-3-(4-methoxyphenyl)-2-methyl-4
     <italic>H</italic>-chromen-4-one (
     <bold>48</bold>)
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Significant inhibition of TRAP in NF-kB ligand-induced osteoclastic RAW 264.7 cells (57.32 ± 2.46%)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B47-molecules-26-00264" ref-type="bibr">47</xref>]
    </td>
   </tr>
  </tbody>
 </table>
</table-wrap>
